Bifidobacterium breve M-16V and Increased Blood Glucose Levels

• Risk factors for hyperglycemia in extremely low birth weight infants during the first 14 days.

  • 2022-01
  • Observational · n = 23
  • Pediatrics and neonatology 63(1)
  • • Yuka Inage
    • Daishi Hirano
    • Ai Nakagawa
    • Saya Yamada
    • Yuko Kotake
    • Naohiro Ikoma
    • Kensuke Kumazawa
    • Shion Hayashi
    • Yukitoshi Tanabe
    • Masahisa Kobayashi
    • Masaki Shimizu

  • PubMed: 34330686
  • DOI: 10.1016/j.pedneo.2021.07.001

  1 Insight on

  • Increased Blood Glucose Levels

  • Low evidence
  • Infants

  Further, Bifidobacterium breve (B. breve M-16V) use was related to hyperglycemia in ELBWIs (HR, 2.95; 95% CI, 1.10-7.87; P=0.031).

  Effect

  Harmful

  Effect size

  Large

  Significant

  Yes